The US FDA has granted priority review to AstraZeneca's sBLA for Imfinzi (durval...
The US FDA has granted RMAT designation to Affimed and Artiva Biotherapeutics’ c...
The FDA has granted accelerated approval to Merus’ Bizengri in the treatment of ...
Dewpoint Therapeutics and MTPC have entered a strategic research partnership foc...
LEO Pharma has gained marketing authorisation from the MHRA for Anzupgo to treat...
The new FDA guidance outlines how surrogate or intermediate clinical endpoints c...
A study published in Nature estimates the economic burden associated with obesit...
Investment for companies developing cell and gene therapies (CGTs) was discussed...
Eli has announced a $3bn investment to expand its newly acquired manufacturing f...
Centenarians present a unique opportunity for researchers to explore longevity, ...
Muna has entered a research alliance with GSK to expedite Alzheimer's disease tr...
The US FDA has granted RMAT designation to Affimed and Artiva Biotherapeutics’ c...
Lundbeck has completed the acquisition of all outstanding shares of Longboard Ph...
The US FDA has approved AstraZeneca's Imfinzi (durvalumab), to treat limited-sta...
US police have confirmed that Brian Thompson was fatally shot outside an investo...
An open-label Phase III trial showed that participants using Zepbound saw 47% gr...
